Internal Medicine, Rheumatology · Caguas, PR
NPI
1144453317
Since 2009
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
14 Ave Luis Munoz Marin, Villa Blanca
Caguas, PR, 00725
Phone (787) 743-0338
Medicare paid, 2023
$1,698
25 services
Medicare patients, 2023
14
Average age 68
Drug cost, 2024
$3.7M
4,169 prescriptions
Company payments, 2025
$730
From 6 companies
Medicare prescription drug claims, 2024
In 2024, the drug Leyda M Diaz-Correa prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 560 prescriptions and refills. In total Leyda M Diaz-Correa wrote 4,169 Medicare prescriptions that cost $3.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Methotrexate Methotrexate Sodium | 560 | 576 | 83 | $8,412 |
| Gabapentin Generic | 525 | 605 | 108 | $4,184 |
| Hydroxychloroquine Sulfate Generic | 376 | 440 | 74 | $8,623 |
| Prednisone Generic | 236 | 246 | 42 | $1,302 |
| Pregabalin Generic | 204 | 206 | 38 | $4,086 |
| Duloxetine Hcl Generic | 204 | 241 | 55 | $2,498 |
| Alendronate Sodium Generic | 185 | 214 | 36 | $1,341 |
| Humira(Cf) Pen Adalimumab | 176 | 176 | 21 | $1.2M |
| Diclofenac Potassium Generic | 172 | 180 | 49 | $4,933 |
| Meloxicam Generic | 131 | 131 | 39 | $602 |
| Diclofenac Sodium Generic | 99 | 108 | 22 | $1,473 |
| Tizanidine Hcl Generic | 90 | 90 | 20 | $911 |
| Orencia Clickject Abatacept | 89 | 89 | 12 | $506K |
| Cyclobenzaprine Hcl Generic | 65 | 65 | 20 | $313 |
| Mycophenolate Mofetil Generic | 58 | 64 | 12 | $2,643 |
Brand drugs: 724 claims; generic drugs: 3,445 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leyda M Diaz-Correa $730 ($730 in general payments such as food, travel and fees) from 6 companies. The largest payer was GlaxoSmithKline, LLC. with $256.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.